Differential RNA expression of KIR alleles

Immunogenetics

Volumn 62, Issue 7, 2010, Pages 431-440

  McErlean, Colum ^a   Gonzalez, Asensio A ^a   Cunningham, Rodat ^b   Meenagh, Ashley ^a   Shovlin, Tanya ^a   Middleton, Derek ^c  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Alleles; Gene expression; Genotyping; Killer cell immunoglobulin like receptor; Real time polymerase chain reaction

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; RNA;

ALLELE; ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; GENE DELETION; GENE EXPRESSION; GENOTYPE; HETEROZYGOSITY; HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

ALLELES; GENE DOSAGE; GENE FREQUENCY; GENOTYPE; HUMANS; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3; RECEPTORS, KIR3DL1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77954427523     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-010-0449-9     Document Type: Article

References (50)

1. KE Baker R Parker 2004 Nonsense-mediated mRNA decay: terminating erroneous gene expression Curr Opin Cell Biol 16 293 299 10.1016/j.ceb.2004.03. 003 15145354 1:CAS:528:DC%2BD2cXktVCqsbY%3D (Pubitemid 38610410)
2. JD Barbour U Sriram SJ Caillier JA Levy FM Hecht JR Oksenberg 2007 Synergy or independence? Deciphering the interaction of HLA class I and NK cell KIR alleles in early HIV-1 disease progression PLoS Pathog 3 e43 10.1371/journal.ppat.0030043 17447840 1:CAS:528:DC%2BD2sXkvFSnur4%3D (Pubitemid 46683481)
3. S Becker T Tonn T Fussel M Uhrberg M Bogdanow E Seifried C Seidl 2003 Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands Hum Immunol 64 183 193 10.1016/S0198-8859(02)00802-9 12559621 1:CAS:528:DC%2BD3sXmsVyiug%3D%3D (Pubitemid 36197347)
4. LR Bisset TL Lung M Kaelin E Ludwig RW Dubs 2004 Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland Eur J Haematol 72 203 212 10.1046/j.0902-4441.2003. 00199.x 14962239 (Pubitemid 38250798)
5. PR Buckland 2004 Allele-specific gene expression differences in humans Hum Mol Genet 13 R255 R260 10.1093/hmg/ddh227 15358732 1:CAS:528: DC%2BD2cXns1Omt7w%3D (Pubitemid 39359910)
6. M Buhler F Mohn L Stalder O Muhlemann 2005 Transcriptional silencing of nonsense codon-containing immunoglobulin minigenes Mol Cell 18 307 317 10.1016/j.molcel.2005.03.030 15866173 1:CAS:528:DC%2BD2MXkt1Cgtbo%3D (Pubitemid 41350536)
7. WH Carr MJ Pando P Parham 2005 KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand J Immunol 175 5222 5229 16210627 1:CAS:528:DC%2BD2MXhtVylsbbI
8. A Cerwenka CS Falk C Watzl 2007 NK cells-from basic research to cancer therapy Eur J Immunol 37 1161 1164 10.1002/eji.200790017 17447232 1:CAS:528:DC%2BD2sXls1Oqu7k%3D (Pubitemid 46925299)
9. S Cooley E Trachtenberg TL Bergemann K Saeteurn J Klein CT Le SG Marsh LA Guethlein P Parham JS Miller DJ Weisdorf 2009 Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia Blood 113 726 732 10.1182/blood-2008-07-171926 18945962 1:CAS:528:DC%2BD1MXht1Wntr8%3D
10. S Cooley F Xiao M Pitt M Gleason V McCullar TL Bergemann KL McQueen LA Guethlein P Parham JS Miller 2007 A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature Blood 110 578 586 10.1182/blood-2006-07-036228 17392508 1:CAS:528: DC%2BD2sXot1emtr0%3D (Pubitemid 47105396)
11. L Denis K Gagne B Gueglio N Kerdudou N Milpied P Simon G Follea M Bonneville JL Harousseau JD Bignon 2005 NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation Hum Immunol 66 447 459 10.1016/j.humimm.2005.01.008 15935882 1:CAS:528:DC%2BD2MXltVeis7k%3D (Pubitemid 40797543)
12. H Fujisaki H Kakuda N Shimasaki C Imai J Ma T Lockey P Eldridge WH Leung D Campana 2009 Expansion of highly cytotoxic human natural killer cells for cancer cell therapy Cancer Res 69 4010 4017 10.1158/0008-5472.CAN-08-3712 19383914 1:CAS:528:DC%2BD1MXltFOktr8%3D
13. CM Gardiner 2008 Killer cell immunoglobulin-like receptors on NK cells: the how, where and why Int J Immunogenet 35 1 8 18093180 1:CAS:528: DC%2BD1cXhvVWjsLo%3D
14. DG Ginzinger 2002 Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream Exp Hematol 30 503 512 10.1016/S0301-472X(02)00806-8 12063017 1:CAS:528:DC%2BD38XksFOksb8%3D (Pubitemid 34626648)
15. N Gomez-Lozano HI Trompeter R De Pablo E Estefania M Uhrberg C Vilches 2007 Epigenetic silencing of potentially functional KIR2DL5 alleles: implications for the acquisition of KIR repertoires by NK cells Eur J Immunol 37 1954 1965 10.1002/eji.200737277 17557377 1:CAS:528:DC%2BD2sXnslyitb8%3D (Pubitemid 47065131)
16. A Gonzalez A Meenagh C Sleator D Middleton 2008 Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5 Tissue Antigens 72 11 20 10.1111/j.1399-0039.2008.01050.x 18498296 1:CAS:528:DC%2BD1cXptVWgtLY%3D (Pubitemid 351841640)
17. JP Goodridge LJ Lathbury NK Steiner CN Shulse P Pullikotil NG Seidah CK Hurley FT Christiansen CS Witt 2007 Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells Eur J Immunol 37 199 211 10.1002/eji.200636316 17171757 1:CAS:528: DC%2BD2sXhtFGitLk%3D (Pubitemid 46128800)
18. IA Halfpenny D Middleton YA Barnett F Williams 2004 Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1 Hum Immunol 65 602 612 10.1016/j.humimm.2004.03.003 15219380 1:CAS:528: DC%2BD2cXlt1ams7c%3D (Pubitemid 38813411)
19. KC Hsu T Gooley M Malkki C Pinto-Agnello B Dupont JD Bignon M Bornhauser F Christiansen A Gratwohl Y Morishima M Oudshoorn O Ringden JJ van Rood E Petersdorf 2006 KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy Biol Blood Marrow Transplant 12 828 836 10.1016/j.bbmt.2006.04.008 16864053 1:CAS:528: DC%2BD28XpsVagsLw%3D (Pubitemid 44070671)
20. S Imbeaud E Graudens V Boulanger X Barlet P Zaborski E Eveno O Mueller A Schroeder C Auffray 2005 Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces Nucleic Acids Res 33 e56 10.1093/nar/gni054 15800207 (Pubitemid 41748353)
21. O Isken LE Maquat 2007 Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function Genes Dev 21 1833 1856 10.1101/gad.1566807 17671086 1:CAS:528:DC%2BD2sXps1amu7c%3D (Pubitemid 47204924)
22. AD Johnson D Wang W Sadee 2005 Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics Pharmacol Ther 106 19 38 10.1016/j.pharmthera.2004.11.001 15781120 1:CAS:528:DC%2BD2MXisFGlsL0%3D (Pubitemid 40392460)
23. L Keaney F Williams A Meenagh C Sleator D Middleton 2004 Investigation of killer cell immunoglobulin-like receptor gene diversity III. KIR2DL3 Tissue Antigens 64 188 194 10.1111/j.1399-0039.2004.00263.x 15245374 1:CAS:528:DC%2BD2cXmvVehsro%3D (Pubitemid 38969583)
24. SI Khakoo M Carrington 2006 KIR and disease: a model system or system of models? Immunol Rev 214 186 201 10.1111/j.1600-065X.2006.00459.x 17100885 1:CAS:528:DC%2BD28XhtlClsrzM (Pubitemid 44707911)
25. RN Koehler AM Walsh N Moqueet JR Currier MA Eller LA Eller F Wabwire-Mangen NL Michael ML Robb FE McCutchan GH Kijak 2009 High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR Tissue Antigens 74 73 80 10.1111/j.1399-0039.2009.01265.x 19522772 1:CAS:528:DC%2BD1MXovFSgurc%3D
26. S Kulkarni MP Martin M Carrington 2008 The Yin and Yang of HLA and KIR in human disease Semin Immunol 20 343 352 10.1016/j.smim.2008.06.003 18635379 1:CAS:528:DC%2BD1cXhsVCgtr3F
27. W Leung R Iyengar B Triplett V Turner FG Behm MS Holladay J Houston R Handgretinger 2005 Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors J Immunol 174 6540 6545 15879158 1:CAS:528:DC%2BD2MXjvV2lsro%3D
28. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method Methods 25 402 408 10.1006/meth.2001.1262 11846609 1:CAS:528:DC%2BD38XhtFelt7s%3D (Pubitemid 34164012)
29. L Luo Z Du SK Sharma R Cullen S Spellman EF Reed R Rajalingam 2007 Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3 Immunogenetics 59 779 792 10.1007/s00251-007-0239-1 17646980 1:CAS:528:DC%2BD2sXhtFKkt7jK (Pubitemid 47594099)
30. A Meenagh A Gonzalez C Sleator S McQuaid D Middleton 2008 Investigation of killer cell immunoglobulin-like receptor gene diversity, KIR2DL1 and KIR2DS1 Tissue Antigens 72 383 391 10.1111/j.1399-0039.2008.01093.x 18643963 1:CAS:528:DC%2BD1cXht1GktL7O
31. D Middleton A Gonzalez PM Gilmore 2007 Studies on the expression of the deleted KIR2DS4 003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations Hum Immunol 68 128 134 10.1016/j.humimm.2006.12.007 17321903 1:CAS:528:DC%2BD2sXitFyksL8%3D (Pubitemid 46282218)
32. D Middleton A Meenagh PA Gourraud 2007 KIR haplotype content at the allele level in 77 Northern Irish families Immunogenetics 59 145 158 10.1007/s00251-006-0181-7 17200871 1:STN:280:DC%2BD2s%2FjtVWrsg%3D%3D (Pubitemid 46130793)
33. TJ Mulrooney L Hou NK Steiner M Chen I Belle J Ng CK Hurley 2008 Promoter variants of KIR2DL5 add to diversity and may impact gene expression Immunogenetics 60 287 294 10.1007/s00251-008-0273-7 18461314 1:CAS:528:DC%2BD1cXmsValt74%3D
34. MJ Pando CM Gardiner M Gleimer KL McQueen P Parham 2003 The protein made from a common allele of KIR3DL1 (3DL1 004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1 J Immunol 171 6640 6649 14662867 1:CAS:528:DC%2BD3sXpsV2rt7o%3D
35. B Perussia Y Chen MJ Loza 2005 Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell Mol Immunol 42 385 395 10.1016/j.molimm.2004.07.017 15607789 1:CAS:528:DC%2BD2cXhtVyktr3N (Pubitemid 39655944)
36. S Ravet D Scott-Algara E Bonnet HK Tran T Tran N Nguyen LX Truong I Theodorou F Barre-Sinoussi G Pancino P Paul 2007 Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals Blood 109 4296 4305 10.1182/blood-2006-08-040238 17272507 1:CAS:528:DC%2BD2sXls1ams78%3D (Pubitemid 46743396)
37. J Robinson MJ Waller P Stoehr SG Marsh 2005 IPD-the Immuno Polymorphism Database Nucleic Acids Res 33 D523 D526 10.1093/nar/gki032 15608253 1:CAS:528:DC%2BD2MXisVektg%3D%3D (Pubitemid 40207929)
38. HG Shilling N Young LA Guethlein NW Cheng CM Gardiner D Tyan P Parham 2002 Genetic control of human NK cell repertoire J Immunol 169 239 247 12077250 1:CAS:528:DC%2BD38XltVKisr0%3D
39. BIS Srivastava MD Srivastava 2006 Expression of natural cytotoxicity receptors NKp30, NKp44, and NKp46 mRNAs and proteins by human hematopoietic and non-hematopoietic cells Leuk Res 30 37 46 10.1016/j.leukres.2005.06.020 16061284 1:CAS:528:DC%2BD2MXht1GnsL3O (Pubitemid 41654703)
40. R Thomas E Yamada G Alter MP Martin AA Bashirova PJ Norman M Altfeld P Parham SK Anderson DW McVicar M Carrington 2008 Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J Immunol 180 6743 6750 18453594 1:CAS:528:DC%2BD1cXltlCkuro%3D
41. A Thompson AR van der Slik F Koning Bergen J Van 2006 An improved RT-PCR method for the detection of killer-cell immunoglobulin-like receptor (KIR) transcripts Immunogenetics 58 865 872 10.1007/s00251-006-0163-9 17033821 1:CAS:528:DC%2BD28Xht1ert7%2FN (Pubitemid 44813045)
42. M Uhrberg 2005 Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation Mol Immunol 42 471 475 10.1016/j.molimm.2004.07.029 15607801 1:CAS:528:DC%2BD2cXhtVyktrvL (Pubitemid 39655956)
43. CJ VandenBussche S Dakshanamurthy PE Posch CK Hurley 2006 A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain J Immunol 177 5347 5357 17015720 1:CAS:528:DC%2BD28XhtVansrnE
44. CJ VandenBussche TJ Mulrooney WR Frazier S Dakshanamurthy CK Hurley 2009 Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule Genes Immun 10 162 173 10.1038/gene.2008.91 19005473 1:CAS:528:DC%2BD1MXisFeltL0%3D
45. C Vilches J Castano N Gomez-Lozano E Estefania 2007 Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments Tissue Antigens 70 415 422 10.1111/j.1399-0039.2007.00923.x 17854430 1:CAS:528:DC%2BD2sXhtlaktr%2FL (Pubitemid 47537402)
46. T Walzer S Jaeger J Chaix E Vivier 2007 Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses Curr Opin Immunol 19 365 372 10.1016/j.coi.2007.04.004 17442558 1:CAS:528:DC%2BD2sXlt1agt7w%3D (Pubitemid 46687010)
47. RB Williams EK Chan MJ Cowley PF Little 2007 The influence of genetic variation on gene expression Genome Res 17 1707 1716 10.1101/gr.6981507 18063559 1:CAS:528:DC%2BD2sXhsVGhsLjN (Pubitemid 351359994)
48. WH Yan A Lin BG Chen MY Zhou MZ Dai XJ Chen LH Gan M Zhu WW Shi BL Li 2007 Possible roles of KIR2DL4 expression on uNK cells in human pregnancy Am J Reprod Immunol 57 233 242 10.1111/j.1600-0897.2007.00469.x 17362384 1:CAS:528:DC%2BD2sXltFWnsrg%3D (Pubitemid 46394835)
49. M Yawata N Yawata M Draghi AM Little F Partheniou P Parham 2006 Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function J Exp Med 203 633 645 10.1084/jem.20051884 16533882 1:CAS:528:DC%2BD28XjsVSqtbY%3D
50. Y You BG Moreira MA Behlke R Owczarzy 2006 Design of LNA probes that improve mismatch discrimination Nucleic Acids Res 34 e60 10.1093/nar/gkl175 16670427 1:CAS:528:DC%2BD28Xks1Smtrg%3D (Pubitemid 43985690)